LGALS3 and type 1 diabetes mellitus: Thus, we speculate that the LPS-induced monocyte/macrophage inflammation is mainly responsible for the elevated circulating Galectin-3 levels in patients with T1D and individuals at high risk for T1D, which could be regarded as a promising clinical biomarker for T1D.